Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M Florentin, EN Liberopoulos, DP Mikhailidis & Elisaf MS. (2008) Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 9:10, pages 1705-1720.
Read now
Read now
Articles from other publishers (8)
Fatemeh Koohi, Nooshin Ahmadi, Fereidoun Azizi, Davood Khalili & Majid Valizadeh. (2022) Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study. Journal of Translational Medicine 20:1.
Crossref
Crossref
Dina M. KhodeerSawsan A. ZaitoneNoha E. FaragYasser M. Moustafa. (2016) Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis. Canadian Journal of Physiology and Pharmacology 94:5, pages 463-476.
Crossref
Crossref
Sanja S. Soskić, Branislava D. Dobutović, Emina M. Sudar, Milan M. Obradović, Dragana M. Nikolić, Božidarka L. Zarić, Srđan Đ. Stojanović, Edita J. Stokić, Dimitri P. Mikhailidis & Esma R. Isenović. (2011) Peroxisome Proliferator-Activated Receptors and Atherosclerosis. Angiology 62:7, pages 523-534.
Crossref
Crossref
Laura A. MaileWalker H. BusbyTimothy C. NicholsDwight A. BellingerElizabeth P. MerricksMichael RowlandUmadevi VeluvoluDavid R. Clemmons. (2010)
A Monoclonal Antibody Against α
V
β
3
Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs
. Science Translational Medicine 2:18.
Crossref
Crossref
Angela Botts & Medha Munshi. (2008) Diabetes in the elderly. Current Cardiovascular Risk Reports 2:5, pages 382-389.
Crossref
Crossref
Kosmas I. Paraskevas, Nikolaos Bessias, Theofanis T. Papas, Christos D. Gekas, Vassilios Andrikopoulos & Dimitri P. Mikhailidis. (2008) Do Different Vascular Risk Factors Affect All Arteries Equally?. Angiology 59:4, pages 397-401.
Crossref
Crossref
David C. Klonoff. (2008) Personalized Medicine for Diabetes. Journal of Diabetes Science and Technology 2:3, pages 335-341.
Crossref
Crossref
A. J. Scheen. (2008) CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant. Journal of Neuroendocrinology 20:s1, pages 139-146.
Crossref
Crossref